Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Disorder Mania

This study has been terminated.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
University Hospital Case Medical Center
ClinicalTrials.gov Identifier:
NCT00194064
First received: September 13, 2005
Last updated: December 5, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2007
  Estimated Primary Completion Date: No date given